JP2024532729A5 - - Google Patents
Info
- Publication number
- JP2024532729A5 JP2024532729A5 JP2024507151A JP2024507151A JP2024532729A5 JP 2024532729 A5 JP2024532729 A5 JP 2024532729A5 JP 2024507151 A JP2024507151 A JP 2024507151A JP 2024507151 A JP2024507151 A JP 2024507151A JP 2024532729 A5 JP2024532729 A5 JP 2024532729A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- tautomer
- compound
- pharmaceutically acceptable
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021111481 | 2021-08-09 | ||
| CNPCT/CN2021/111481 | 2021-08-09 | ||
| PCT/CN2022/111129 WO2023016447A1 (en) | 2021-08-09 | 2022-08-09 | Ferroptosis modulators, preparations, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532729A JP2024532729A (ja) | 2024-09-10 |
| JP2024532729A5 true JP2024532729A5 (cg-RX-API-DMAC7.html) | 2025-08-18 |
Family
ID=85199873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024507151A Pending JP2024532729A (ja) | 2021-08-09 | 2022-08-09 | フェロトーシス調節物質、その調製及び使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240360114A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4384493A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024532729A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118076581A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3227251A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL310387A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023016447A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202513069A (zh) | 2023-07-21 | 2025-04-01 | 美商冰洲石生物科技公司 | 作為週期蛋白依賴性激酶抑制劑之胺基嘧啶衍生物 |
| WO2026034623A1 (ja) * | 2024-08-09 | 2026-02-12 | 住友ファーマ株式会社 | アミノメチルシクロヘキサン誘導体 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1306450A (en) * | 1970-08-22 | 1973-02-14 | Pfizer Ltd | Mono-alkyl-substituted diarylamino- and aryl-4-alkyl-benzyl-amino- alkylamines |
| JP3280040B2 (ja) * | 1990-03-26 | 2002-04-30 | 武田薬品工業株式会社 | アミノベンゼン化合物 |
| SE0004054D0 (sv) * | 2000-11-06 | 2000-11-06 | Astrazeneca Ab | N-type calcium channel antagonists for the treatment of pain |
| SA08290668B1 (ar) * | 2007-10-25 | 2012-02-12 | شيونوجي آند كو.، ليمتد | مشتقات أمين لها نشاط مضاد لمستقبل npy y5 واستخداماتها |
| US8227618B2 (en) * | 2009-04-23 | 2012-07-24 | Shionogi & Co., Ltd. | Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof |
| US9580398B2 (en) * | 2012-04-02 | 2017-02-28 | The Trustees Of Columbia University In The City Of New York | Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders |
| EP3076962A4 (en) * | 2013-12-02 | 2017-10-18 | The Trustees of Columbia University in the City of New York | Modulating ferroptosis and treating excitotoxic disorders |
| GB201420235D0 (en) * | 2014-11-14 | 2014-12-31 | Vib Vzw And Universiteit Antwerpen And Universiteit Gent | Compounds for inhibiting cell death |
| ES2901617T3 (es) * | 2016-12-14 | 2022-03-23 | Glaxosmithkline Ip Dev Ltd | Bisarilamidas como reguladores de NRF2 |
| EP3651762B1 (en) * | 2017-07-12 | 2024-07-03 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor m4 |
| JP7270989B2 (ja) * | 2017-10-20 | 2023-05-11 | ヴァンダービルト ユニバーシティー | ムスカリン性アセチルコリン受容体m4のアンタゴニスト |
| WO2019106434A1 (en) * | 2017-12-01 | 2019-06-06 | Collaborative Medicinal Development Pty. Ltd. | Heterobicyclic aromatic derivatives for the treatment of ferroptosis-related disorders |
| EP3887351A4 (en) * | 2018-11-27 | 2022-11-02 | The Trustees of Columbia University in the City of New York | COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATION OF FERROPTOSE AND TREATMENT OF EXCITOTOXIC DISORDERS |
| CN113631535B (zh) * | 2019-03-11 | 2024-04-12 | 协同医药发展有限公司 | 治疗铁死亡相关紊乱的杂芳基和双杂环芳基衍生物 |
-
2022
- 2022-08-09 IL IL310387A patent/IL310387A/en unknown
- 2022-08-09 US US18/293,357 patent/US20240360114A1/en active Pending
- 2022-08-09 CA CA3227251A patent/CA3227251A1/en active Pending
- 2022-08-09 CN CN202280068267.7A patent/CN118076581A/zh active Pending
- 2022-08-09 JP JP2024507151A patent/JP2024532729A/ja active Pending
- 2022-08-09 EP EP22855428.3A patent/EP4384493A4/en active Pending
- 2022-08-09 WO PCT/CN2022/111129 patent/WO2023016447A1/en not_active Ceased